ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,428,000 | -37.2% | 84,802 | -10.7% | 0.01% | -33.3% |
| Q2 2015 | $5,461,000 | +15.7% | 94,960 | +28.0% | 0.01% | 0.0% |
| Q1 2015 | $4,722,000 | +18.1% | 74,192 | +14.5% | 0.01% | +28.6% |
| Q4 2014 | $3,997,000 | +77.0% | 64,776 | +11.3% | 0.01% | +75.0% |
| Q3 2014 | $2,258,000 | +24.9% | 58,176 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $1,808,000 | +156.8% | 58,176 | +165.3% | 0.00% | +200.0% |
| Q1 2014 | $704,000 | +95.6% | 21,927 | +201.2% | 0.00% | 0.0% |
| Q4 2013 | $360,000 | -61.6% | 7,280 | -70.9% | 0.00% | -50.0% |
| Q3 2013 | $938,000 | +25.7% | 25,009 | -9.9% | 0.00% | +100.0% |
| Q2 2013 | $746,000 | – | 27,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |